TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient CareJune 30, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced the launch of a new clinical diagnostics immuno-oncology service, TissueInsight....
News
News and Insights from Our Multidisciplinary Team of Experts
Biomarkers Strategies and Implementation for Drug Development (Regulatory Webcast Summary)
Flagship Biosciences recently hosted a webcast on Biomarkers: Strategies and Implementation, and Drug Development. Introduced by our COO Meredith James, we were pleased to have our colleague Suzana Corritori, MD, PhD, MSc present her thoughts on a strategic approach...
Flagship Spotlight: Caroline Chandler
Caroline Chandler, Flagship Project Manager, graduated from Colorado State University with a Bachelor of Science degree in sports medicine. Caroline shared her thoughts about her career and working at Flagship in this spotlight article.Early Cancer Treatment...
Flagship Spotlight: Cris Luengo, PhD
Cris Luengo, PhD, is Director of Image Analysis at Flagship Biosciences. Cris has a PhD in Image Analysis and an MSc in Applied Physics, both from Delft University of Technology, The Netherlands. Cris shared some experiences that led him to Flagship, as well as...
Flagship Biosciences Names Aymii Couzelis as Chief Information Officer
Westminster, CO — May 27, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced that Aymii Couzelis has been named to its executive team as Chief Information Officer. Aymii brings over 20 years of experience leading IT and product...
Flagship Spotlight: Mandy Bell
Mandy Bell is certified as a histotechnologist (HTL) by the American Society for Clinical Pathology (ASCP) and is the laboratory manager at Flagship Biosciences. Mandy received a BS in biology from Colorado State University. She said she has always wanted to be a...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
PUBLICATIONS/POSTERS
Comprehensive Image Analysis Of Immunostained NSCLC Tissues Provides Necessary Context For Immune Oncology Biomarker Profiling
Key Takeaways Manual pathology assessment is challenging and variable, limiting the data interpretation required for meaningful spatial biology analysis Unlike manual assessment, artificial intelligence and machine learning technologies analyze the complex...
Artificial Intelligence Assisted Macrophage Identification in Tumor Biopsies
Key Takeaways Classifying macrophages is important in understanding response to immunotherapy, but it may be challenging to do by eye Using an immunofluorescence-guided machine learning algorithm provided accurate macrophage classification This algorithm is useful in...
Analysis of Companion Diagnostic Potentials For Multifaceted PD-L1 Assays
ABSTRACT In vitro diagnostic (IVD) approvals of qualitative immunohistochemical (IHC) assays offer unique patient selection strategies by equipping pathologists with new tools to assess tumor status including tumor immune landscape. PD-L1/PD-1 checkpoint therapies...
EVENTS
Utilizing RNAscope in the clinic: Why you need image analysis to handle the complexity
Utilizing RNAscope in the clinic to handle complex analysis. RNAscope is rapidly becoming a solution for understanding complex biomarker challenges. The benefits and awareness of image analysis in the space of pathology have been widely discussed and rapidly growing....
Precision Patient Care: Seamless Optimization of Diagnoses, Companion Testing and Therapy Design
Technology Leads the Way to Precision Patient Care Digital transformation comes in many flavors. In pathology, it can be as simple as merely scanning pathology slides into whole slide images. However, it can also represent end-to-end digital pathology workflow...
Pathology Visions 2021
Pathology Visions 2021October 17-19, 2021Digital Pathology: The Future is Here is the theme of this year’s Digital Pathology Association annual conference, Pathology Visions 2021. #PathVisions21 featured a poster from Flagship’s CCO Meredith James on a novel approach...